---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-001892"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T00:53:39.137061+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics regains Nasdaq minimum bid price compliance; stock continues listing

## Summary
- Received Nasdaq notice confirming compliance with minimum bid price rule (Rule 5550(a)(2)).
- Compliance met on Jan 4, 2024 after 10 consecutive trading days with closing bid price over $1.00.
- Stock will continue on Nasdaq Capital Market under discretionary panel monitor until June 28, 2024.
- Previously notified of deficiency on Sep 27, 2023 for failing to maintain $1.00 closing bid for 30 days.

## SEC filing metadata
- accession: 0001493152-24-001892
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224001892/0001493152-24-001892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224001892/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-001892
- JSON: https://secwatch.observer/filing/0001493152-24-001892.json
- Plain text: https://secwatch.observer/filing/0001493152-24-001892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.